This week, I had the privilege of participating in AMIIF Innovation Week, which featured three extraordinary panels moderated by Dr. Georgina García. These discussions, led by prominent figures, covered crucial topics such as improving access to innovation in healthcare and the challenges of fostering collaboration among all ecosystem actors.
Despite the moments of optimism, the discussions have left me reflecting on the persistent issues of inequality and inequity within Mexico's healthcare system.
A significant focus was on integrating artificial intelligence to advance treatments for chronic diseases, enhance personalized medicine, and scale vaccine development. However, for AI to become a primary tool for timely diagnoses, several foundational steps are still needed. For instance, a unified and systematized electronic medical record system is essential for feeding AI with comprehensive data. Additionally, there is a need for universal coverage to ensure that patients receive necessary treatments regardless of their healthcare affiliation.
These challenges present opportunities for progress, particularly if we adopt an innovative model similar to that of Israel, where the healthcare ecosystem strives to provide top-tier care with the latest technologies and medications to all citizens. In Mexico, achieving this requires urgent action from the three key players in the innovation triangle: academia, decision-makers, and the private sector. We are confident that, with each party contributing their expertise, we can overcome these obstacles and drive meaningful change.
Comments